Cardinal Health, Inc. $CAH Shares Sold by American Century Companies Inc.

American Century Companies Inc. decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 90.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 61,470 shares of the company’s stock after selling 575,170 shares during the quarter. American Century Companies Inc.’s holdings in Cardinal Health were worth $10,327,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the company. Harbour Investments Inc. grew its holdings in Cardinal Health by 8.0% during the 1st quarter. Harbour Investments Inc. now owns 1,254 shares of the company’s stock valued at $173,000 after purchasing an additional 93 shares in the last quarter. Empower Advisory Group LLC boosted its position in Cardinal Health by 7.0% in the 1st quarter. Empower Advisory Group LLC now owns 2,153 shares of the company’s stock valued at $297,000 after buying an additional 141 shares during the last quarter. Exencial Wealth Advisors LLC grew its stake in shares of Cardinal Health by 2.1% during the first quarter. Exencial Wealth Advisors LLC now owns 5,673 shares of the company’s stock valued at $782,000 after acquiring an additional 115 shares in the last quarter. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Cardinal Health during the first quarter worth about $26,000. Finally, ASR Vermogensbeheer N.V. acquired a new position in shares of Cardinal Health in the first quarter worth about $7,592,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.4%

NYSE:CAH opened at $198.97 on Friday. The stock has a fifty day simple moving average of $181.69 and a 200 day simple moving average of $164.74. The firm has a market capitalization of $47.27 billion, a price-to-earnings ratio of 30.01, a price-to-earnings-growth ratio of 1.45 and a beta of 0.63. Cardinal Health, Inc. has a 1-year low of $114.60 and a 1-year high of $214.93.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the previous year, the company earned $1.88 EPS. The business’s revenue for the quarter was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Wall Street Analysts Forecast Growth

CAH has been the subject of a number of recent analyst reports. UBS Group raised their price objective on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Mizuho upped their price target on Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. Citigroup increased their price objective on shares of Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research note on Friday, October 31st. Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a research note on Tuesday, November 18th. Finally, Wells Fargo & Company upped their target price on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Twelve equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.